During the past decade, Toho University Ohashi Medical Center conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toho University Ohashi Medical Center" #1 sponsor was "Boston Scientific Corporation" with 5 trials, followed by "Haruhiko Fukuda" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Alexion" with 2 trials sponsored and "Associations for Establishment of Evidence in Interventions" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toho University Ohashi Medical Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "Boston Scientific Japan K.K." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Toho University Ohashi Medical Center" are "Coronary Artery Disease" (8 trials), "Rheumatoid Arthritis" (3 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Diseases" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Toho University Ohashi Medical Center" in a lesser frequency.

Most popular intervention types in "Toho University Ohashi Medical Center" are "Drug" (22 trials), "Device" (15 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "3 months of dual antiplatelet therapy (DAPT)" (1 trials), "5FU+l-leucovorin" (1 trials), "ALXN1840" (1 trials) and "Abbott Laboratories Xience" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toho University Ohashi Medical Center" are 40 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Toho University Ohashi Medical Center". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Toho University Ohashi Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Toho University Ohashi Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 11 trials that are defined as “Not Applicable".

Toho University Ohashi Medical Center has several departments that took part in Clinical trials: "Toyohashi Heart Center" - 2 trials